New Key Statistics Module, Z-Score and F-Score
TSX:GUD Key Ratios
Market Cap C$ M | 578.70 |
Enterprise Value C$ M | 477.62 |
P/E(ttm) | -- |
PE Ratio without NRI | 48.91 |
Forward PE Ratio | 95.24 |
Price/Book | 0.79 |
Price/Sales | 1.91 |
Price/Free Cash Flow | 23.85 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) C$ M | 328.00 |
EPS (TTM) C$ | -0.16 |
Beneish M-Score | -2.61 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 9.00 |
y-y EBITDA Growth Rate % | 73.20 |
EV-to-EBIT | -50.28 |
EV-to-EBITDA | 11.68 |
PEG | 5.43 |
Shares Outstanding M | 101.17 |
Net Margin (%) | -5.13 |
Operating Margin % | 1.94 |
Pre-tax Margin (%) | -6.70 |
Quick Ratio | 2.40 |
Current Ratio | 3.20 |
ROA % (ttm) | -1.66 |
ROE % (ttm) | -2.10 |
ROIC % (ttm) | 0.66 |
Dividend Yield % | -- |
Altman Z-Score | 2.63 |
TSX:GUD Number of Guru Trades
TSX:GUD Volume of Guru Trades
Gurus Latest Trades with TSX:GUD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
TSX:GUD is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Knight Therapeutics Inc Insider Transactions
No Available Data